Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Stock Market
Government
Executive Activities
Banking
Corporate Performance
Economic News
International and US Foreign Trade
Aerospace & Defense
Commodities & Futures
Table bottom

Cancer & Oncolgy
"Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period" Download the full report: https://www.reportbuyer.com/product/5206184 The tissue diagnostics market is expected to reach USD 5.14...
PR Newswire, 9:28pm ET



A small protein modification can trigger the aggressive migratory and invasive properties of prostate cancer cells, according to new research published on the cover of Oncotarget. The findings give greater insight into how cancers can move from...
PR Newswire, 5:58pm ET

Overland Park, Kansas - November 20, 2017 - The recent reports from the Department of Urology indicates that more than 200,000 men are affected by prostate cancer each year and it is more common in mean who are 50 and older and men with a family...
ABNewswire, 5:53pm ET

THE much awaited National Cancer Treatment Guidelines, which are envisioned to assist the government have proper forecast of cancer medicines and other services, are in their final stages. The Ocean Road Cancer Institute (ORCI) Executive...
All Africa Global Media, 4:13am ET

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) and Pfizer Global Medical Grants today announced they have awarded funding to nine projects that use clinical care pathways to implement quality improvement (QI)...
PR Newswire, 2:38pm ET

The Inaugural event will take place at the Pickleball facility at Sun City West and feature players from all over the world fighting for a World Championship</p> SUN CITY WEST, ARIZONA, UNITED STATES, November 20, 2017 /EINPresswire.com/ --...
EIN News, 2:38pm ET

The "Innovations in Whole Body Functional Imaging, Improved Patient Comfort During Mammography, Artificial Intelligence in Imaging Analytics and 3D Medical Image Visualization" newsletter has been added to Research and...
BusinessWire, 11:03am ET

The Global Liquid Biopsy Market is currently valued at $ 3950 Million and will reach $ 17,372.28 Million growing at a CAGR of 28%. A liquid biopsy is a largely non-invasive, sampling and analysis of liquid state biological tissue for...
ABNewswire, 10:33am ET

--In line with recent publications from NEJM and ASCO, the AJCC now recognizes MammaPrint with Level I evidence for determining clinical prognosis, which is the basis for chemotherapy treatment decisions Agendia, Inc., a world leader in...
BusinessWire, 9:08am ET

According to a new market research report "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering), End User (Biotechnology &amp;...
PR Newswire, 8:38am ET

PUNE, India, November 20, 2017 /PRNewswire/ -- According to a new market research report "Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN), Application (Cell Line Engineering, Animal Genetic Engineering, Plant...
PR Newswire Europe, 8:38am ET

Janssen-Cilag International NV (Janssen) today announced that the European Commission (EC) has granted approval to broaden the existing marketing authorisation for ZYTIGA(R) (abiraterone acetate) plus prednisone /...
BusinessWire, 8:38am ET

Volpara Solutions announced today that it has received regulatory clearances for its suite of quantitative breast imaging tools in Japan and Taiwan. In Japan, the full Volpara®Enterprise(TM) suite of products has received regulatory approval as...
PR Newswire, 8:08am ET

- Pivotal phase 2 DESTINY-Gastric01 study in Japan and South Korea will evaluate efficacy and safety of DS-8201 in HER2-positive advanced gastric cancer resistant or refractory to trastuzumab - Currently no HER2-targeting therapy is...
PR Newswire Europe, 8:08am ET

The recent Promesa y Esperanza ® (Promise and Hope) national radio event raised funds for St. Jude Children's Research Hospital®, helping to ensure that families never receive a bill from St. Jude for treatment, travel, housing or food -...
PR Newswire, 8:08am ET

Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced positive interim analysis results...
GlobeNewswire, 8:08am ET

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced the first patient has been enrolled in DESTINY-Gastric01, a pivotal phase 2 study in Japan and South Korea evaluating the safety and efficacy of DS-8201, an...
PR Newswire, 8:08am ET

by Ejidiah Wangui Six months ago, Kenya's Joyce Ndanu received the worst news ever -- her doctor confirmed she had breast cancer. Having lost her mother and aunt to breast cancer, Ndanu had long harbored the fear she could be...
Xinhua, 7:43am ET

DUBLIN, November 20, 2017 /PRNewswire/ -- The "Herbal Supplements and Remedies - Global Strategic Business Report" [https://www.researchandmarkets.com/research/rhh46p/herbal] report has been added to Research and Markets' offering....
PR Newswire Europe, 7:38am ET

-- ZEJULA is the first PARP inhibitor approved in Europe for women with recurrent ovarian cancer, regardless of BRCA mutation or biomarker status -- Approval supported by robust data from a randomized, well-controlled Phase 3 trial...
GlobeNewswire, 7:08am ET

1-20 of 165
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.